U.N. Begins Measles Vaccination Campaign In Ebola-Hit DRC Province Amid Calls For Additional Funding For WHO Response

CIDRAP News: CDC’s adapted Ebola virus works in trials, as pressure for funds grows
“[Tuesday] researchers from the Centers for Disease Control and Prevention (CDC) published encouraging findings that showed the antiviral remdesivir and antibodies in the ZMapp treatment regimen were effective in fighting the current strain of Ebola. The findings were published in The Lancet Infectious Diseases. … In order to contain and ultimately end the current Ebola outbreak in the DRC’s North Kivu and Ituri provinces, the United States must fulfill its funding promise to the World Health Organization (WHO), and other nations must also take on the challenge of beating this disease. That’s the message of an editorial [Tuesday] in Nature…” (Soucheray, 7/10).

U.N. News: Mass measles vaccination campaign begins in Ebola-hit DR Congo province
“Health workers have started a massive measles vaccination campaign in north-east Democratic Republic of the Congo (DRC), a region that’s in the grip of the second deadliest Ebola virus outbreak on record. U.N. Children’s Fund UNICEF said on Thursday that it aims to inoculate 67,000 children in Ituri province…” (7/11).

Additional coverage of the DRC Ebola outbreak and response is available from Bloomberg and TIME.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.